Amir Abrishami
Overview
Explore the profile of Amir Abrishami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
1232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Babaei M, Abrishami A, Iranpour S, Saljooghi A, Matin M
Drug Deliv Transl Res
. 2024 Sep;
PMID: 39302530
Despite significant advancements in managing colorectal cancer (CRC), the issues of efficient diagnosis and targeted therapy remain demanding. To address these challenges and improve treatment outcomes while reducing the cost...
2.
Abrishami A, Bahrami A, Nekooei S, Saljooghi A, Matin M
Commun Biol
. 2024 Apr;
7(1):393.
PMID: 38561432
Multimodal nanoparticles, utilizing quantum dots (QDs), mesoporous silica nanoparticles (MSNs), and gold nanoparticles (Au NPs), offer substantial potential as a smart and targeted drug delivery system for simultaneous cancer therapy...
3.
Abrishami A, Bahrami A, Saljooghi A, Matin M
Nanoscale
. 2024 Mar;
16(12):6215-6240.
PMID: 38446130
Using targeted drug delivery systems has emerged as a promising approach to increase the efficacy of chemotherapy, particularly in combination with gene therapy. The overexpression of miR-21 plays a crucial...
4.
Rosenblat J, Lipsitz O, Di Vincenzo J, Rodrigues N, Kratiuk K, Subramaniapillai M, et al.
Psychiatry Res
. 2021 Jul;
303:114086.
PMID: 34246008
Herein we evaluate the impact of COVID-19 restrictions on antidepressant effectiveness of intravenous (IV) ketamine in adults with treatment-resistant depression (TRD). We conducted a case series analysis of adults with...
5.
Maximous R, Wong J, Chung F, Abrishami A
Can J Anaesth
. 2021 Apr;
68(7):1107.
PMID: 33884562
No abstract available.
6.
Maximous R, Wong J, Chung F, Abrishami A
Can J Anaesth
. 2021 Mar;
68(6):880-893.
PMID: 33709263
Background: The objective of this study was to provide a synthesis of the interventions designed to reduce medication errors in anesthetized patients. Methods: We electronically searched major databases using index...
7.
McIntyre R, Rodrigues N, Lee Y, Lipsitz O, Subramaniapillai M, Gill H, et al.
J Affect Disord
. 2020 Jul;
274:903-910.
PMID: 32664031
Background: The effectiveness, tolerability, and safety of intravenous (IV) ketamine in adults with treatment resistant depression (TRD) receiving care in real-word settings is insufficiently characterized. Herein, results from a naturalistic,...
8.
Wong J, Abrishami A, Riazi S, Siddiqui N, You-Ten E, Korman J, et al.
Anesth Analg
. 2017 Mar;
125(2):571-579.
PMID: 28319515
Background: The effectiveness of perioperative interventions to quit smoking with varenicline has not been compared with brief interventions. Our objective was to determine the efficacy of a comprehensive smoking cessation...
9.
Taefi A, Abrishami A, Nasseri-Moghaddam S, Eghtesad B, Sherman M
Cochrane Database Syst Rev
. 2013 Jul;
(6):CD006935.
PMID: 23813393
Background: Hepatocellular carcinoma is a major worldwide health problem, involving more than half a million new patients yearly, with a different incidence in different parts of the world. Hepatocellular carcinoma...
10.
Abdallah F, Abrishami A, Brull R
Anesth Analg
. 2013 May;
117(1):271-8.
PMID: 23632057
Background: Central mechanisms have been proposed to explain the prolongation of effect reported with the off-label use of dexmedetomidine as an adjuvant in local anesthetic admixtures. We evaluated whether IV...